Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

IGI Laboratories Inc announces fourth ANDA submission in 2014

Thursday, 19 Jun 2014 08:00am EDT 

IGI Laboratories Inc:Submits another abbreviated new drug application (ANDA) to the U.S. Food and Drug Administration (FDA), which brings the company's total number of ANDA submissions in 2014 to four, with fifteen submissions pending at the FDA. 

Company Quote

0.84 +8.50%
26 Nov 2014